BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17498654)

  • 1. SUMO modification modulates the transrepression activity of PLZF.
    Chao TT; Chang CC; Shih HM
    Biochem Biophys Res Commun; 2007 Jun; 358(2):475-82. PubMed ID: 17498654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for SUMO modification in facilitating transcriptional repression by BKLF.
    Perdomo J; Verger A; Turner J; Crossley M
    Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMO modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of Daxx.
    Kuo HY; Chang CC; Jeng JC; Hu HM; Lin DY; Maul GG; Kwok RP; Shih HM
    Proc Natl Acad Sci U S A; 2005 Nov; 102(47):16973-8. PubMed ID: 16287980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver receptor homolog-1 localization in the nuclear body is regulated by sumoylation and cAMP signaling in rat granulosa cells.
    Yang FM; Pan CT; Tsai HM; Chiu TW; Wu ML; Hu MC
    FEBS J; 2009 Jan; 276(2):425-36. PubMed ID: 19125815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of promyelocytic leukemia zinc finger protein (PLZF) by SUMO-1 conjugation regulates its transcriptional repressor activity.
    Kang SI; Chang WJ; Cho SG; Kim IY
    J Biol Chem; 2003 Dec; 278(51):51479-83. PubMed ID: 14527952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sumoylation of Drosophila transcription factor STAT92E.
    Grönholm J; Ungureanu D; Vanhatupa S; Rämet M; Silvennoinen O
    J Innate Immun; 2010; 2(6):618-24. PubMed ID: 20616536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMOylation of hypoxia-inducible factor-1alpha reduces its transcriptional activity.
    Berta MA; Mazure N; Hattab M; Pouysségur J; Brahimi-Horn MC
    Biochem Biophys Res Commun; 2007 Aug; 360(3):646-52. PubMed ID: 17610843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox-mediated modification of PLZF by SUMO-1 and ubiquitin.
    Kang SI; Choi HW; Kim IY
    Biochem Biophys Res Commun; 2008 May; 369(4):1209-14. PubMed ID: 18348865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO: a regulator of gene expression and genome integrity.
    Müller S; Ledl A; Schmidt D
    Oncogene; 2004 Mar; 23(11):1998-2008. PubMed ID: 15021887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMOylation of RORalpha potentiates transcriptional activation function.
    Hwang EJ; Lee JM; Jeong J; Park JH; Yang Y; Lim JS; Kim JH; Baek SH; Kim KI
    Biochem Biophys Res Commun; 2009 Jan; 378(3):513-7. PubMed ID: 19041634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daxx mediates SUMO-dependent transcriptional control and subnuclear compartmentalization.
    Shih HM; Chang CC; Kuo HY; Lin DY
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1397-400. PubMed ID: 18031230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMO modification of the DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1.
    Jacobs AM; Nicol SM; Hislop RG; Jaffray EG; Hay RT; Fuller-Pace FV
    Oncogene; 2007 Aug; 26(40):5866-76. PubMed ID: 17369852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIAS proteins are involved in the SUMO-1 modification, intracellular translocation and transcriptional repressive activity of RET finger protein.
    Matsuura T; Shimono Y; Kawai K; Murakami H; Urano T; Niwa Y; Goto H; Takahashi M
    Exp Cell Res; 2005 Aug; 308(1):65-77. PubMed ID: 15907835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sumoylation differentially regulates Goosecoid-mediated transcriptional repression.
    Izzi L; Narimatsu M; Attisano L
    Exp Cell Res; 2008 Apr; 314(7):1585-94. PubMed ID: 18336814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mobility of Bach2 nuclear foci is regulated by SUMO-1 modification.
    Kono K; Harano Y; Hoshino H; Kobayashi M; Bazett-Jones DP; Muto A; Igarashi K; Tashiro S
    Exp Cell Res; 2008 Feb; 314(4):903-13. PubMed ID: 18201693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-dependent kinase antagonizes promyelocytic leukemia zinc-finger through phosphorylation.
    Costoya JA; Hobbs RM; Pandolfi PP
    Oncogene; 2008 Jun; 27(27):3789-96. PubMed ID: 18246121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells.
    Woo CH; Shishido T; McClain C; Lim JH; Li JD; Yang J; Yan C; Abe J
    Circ Res; 2008 Mar; 102(5):538-45. PubMed ID: 18218985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO modification modulates the activity of calpain-2.
    Wang HC; Huang YS; Ho CC; Jeng JC; Shih HM
    Biochem Biophys Res Commun; 2009 Jul; 384(4):444-9. PubMed ID: 19422794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMOylation of Krüppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-delta.
    Oishi Y; Manabe I; Tobe K; Ohsugi M; Kubota T; Fujiu K; Maemura K; Kubota N; Kadowaki T; Nagai R
    Nat Med; 2008 Jun; 14(6):656-66. PubMed ID: 18500350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
    Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
    J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.